Date: 2015-04-09
Type of information: Collaboration agreement
Compound: Proteus®ONE, carbon therapy solutions
Company: IBA (Belgium) Toshiba (Japan)
Therapeutic area: Diagnostic - Cancer - Oncology
Type agreement: collaboration
Action mechanism:
Disease:
Details: * On April 9, 2015, IBA (Ion Beam Applications S.A.) and Toshiba Corporation announced the signing of a global collaboration to expand access to advanced particle therapy worldwide. Toshiba Medical Systems Corporation will become the distributor in Japan for Proteus®ONE, IBA’s compact single-room proton therapy solution, and IBA will become the agent for Toshiba’s Carbon Therapy Solutions outside Japan. IBA and Toshiba will collaborate on activities such as customer education for Proteus®ONE and Toshiba\'s carbon therapy solutions. The collaboration will also enable both organizations to mutually leverage their Operation and Maintenance (O&M) services.
Financial terms:
Latest news:
